The Food and Drug Administration is currently reporting shortages of dextrose in 5%, 10%, 25% and 50% solutions. Manufacturing capacity to support these dextrose products is not expected to improve ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% ...

Patients with chronic tendinosis of the Achilles tendon can experience a reduction in pain when injected with a small amount of a dextrose solution, according to a recent study. Patients with chronic ...

The Food and Drug Administration has given its blessing to Amphastar Pharmaceuticals for dextrose injection 50% in the 50-ml Luer-Jet Prefilled Syringe System. The medication is a sterile, ...

This titrate-up and taper-down controversy stems from concerns regarding the potential for hyperglycemia upon initiation of total parenteral nutrition (TPN) and for hypoglycemia upon discontinuation.

Background: In comparision with children and adults pain in the newborn infants is under assessed and under managed. Recently oral sweet solutions such as sucrose has been used for painful procedures ...

April 12, 2005 — The U.S. Food and Drug Administration (FDA) and PharMEDium Services have alerted healthcare professionals via letter of a nationwide recall of all 50 mL admixtures of magnesium ...